Document is current
Any future updates will be listed below
-
Authors
Norris, Jordan E.
Berry-Kravis, Elizabeth M.
Harnett, Mark D.
Reines, Scott A.
Reese, Melody A.
Outterson, Abigail H.
Michalak, Claire
Furman, Jeremiah
Gurney, Mark E.
Ethridge, Lauren E.
-
Funding
Funding for this research was provided by:
FRAXA Research Foundation
National Institutes of Health (HD076189)
Tetra Therapeutics
- License Information
-
More Information
Article History
Received: 24 May 2024
Accepted: 1 October 2024
First Online: 2 November 2024
Declarations
:
: All study procedures were approved by the Institutional Review Board at Rush University Medical Center; EEG analysis and data management procedures were additionally approved by the Institutional Review Board at University of Oklahoma, following the guidelines of the Declaration of Helsinki. Declaration: All participants or their legal guardians signed informed consent which included consent for EEG data collection.
: N/A.
: J.E.N, E.M.B.-K., L.E.E., M.A.R., A.O., C.M. and J.F. declare no competing interests. M.D.H.and S.D.R. are paid consultants to Tetra Therapeutics. M.E.G. is an employee of TetraTherapeutics, which is a wholly owned subsidiary of Shionogi & Co., Ltd that has a financial interest in BPN14770.
